These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
86 related items for PubMed ID: 26201719
1. Identification of novel target genes specifically activated by deregulated E2F in human normal fibroblasts. Kitamura H, Ozono E, Iwanaga R, Bradford AP, Okuno J, Shimizu E, Kurayoshi K, Kugawa K, Toh H, Ohtani K. Genes Cells; 2015 Sep; 20(9):739-57. PubMed ID: 26201719 [Abstract] [Full Text] [Related]
2. Tumor suppressor TAp73 gene specifically responds to deregulated E2F activity in human normal fibroblasts. Ozono E, Komori H, Iwanaga R, Tanaka T, Sakae T, Kitamura H, Yamaoka S, Ohtani K. Genes Cells; 2012 Aug; 17(8):660-72. PubMed ID: 22702391 [Abstract] [Full Text] [Related]
3. The phosphatidyl inositol 3 kinase pathway does not suppress activation of the ARF and BIM genes by deregulated E2F1 activity. Kurayoshi K, Okuno J, Ozono E, Iwanaga R, Bradford AP, Kugawa K, Araki K, Ohtani K. Biochem Biophys Res Commun; 2017 Jan 22; 482(4):784-790. PubMed ID: 27888102 [Abstract] [Full Text] [Related]
4. The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F. Nakajima R, Deguchi R, Komori H, Zhao L, Zhou Y, Shirasawa M, Angelina A, Goto Y, Tohjo F, Nakahashi K, Nakata K, Iwanaga R, Bradford AP, Araki K, Warita T, Ohtani K. Biochem Biophys Res Commun; 2023 Jun 30; 663():154-162. PubMed ID: 37141667 [Abstract] [Full Text] [Related]
5. Deregulated E2F Activity as a Cancer-Cell Specific Therapeutic Tool. Nakajima R, Zhao L, Zhou Y, Shirasawa M, Uchida A, Murakawa H, Fikriyanti M, Iwanaga R, Bradford AP, Araki K, Warita T, Ohtani K. Genes (Basel); 2023 Feb 02; 14(2):. PubMed ID: 36833320 [Abstract] [Full Text] [Related]
6. Cancer cell specific cytotoxic gene expression mediated by ARF tumor suppressor promoter constructs. Kurayoshi K, Ozono E, Iwanaga R, Bradford AP, Komori H, Ohtani K. Biochem Biophys Res Commun; 2014 Jul 18; 450(1):240-6. PubMed ID: 24893334 [Abstract] [Full Text] [Related]
7. E2F-like elements in p27(Kip1) promoter specifically sense deregulated E2F activity. Ozono E, Komori H, Iwanaga R, Ikeda MA, Iseki S, Ohtani K. Genes Cells; 2009 Jan 18; 14(1):89-99. PubMed ID: 19077036 [Abstract] [Full Text] [Related]
8. Ectopic expression of the CDK inhibitor p21Cip1 enhances deregulated E2F activity and increases cancer cell-specific cytotoxic gene expression mediated by the ARF tumor suppressor promoter. Kurayoshi K, Shiromoto A, Ozono E, Iwanaga R, Bradford AP, Araki K, Ohtani K. Biochem Biophys Res Commun; 2017 Jan 29; 483(1):107-114. PubMed ID: 28042030 [Abstract] [Full Text] [Related]
9. Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression. Wu ZL, Zheng SS, Li ZM, Qiao YY, Aau MY, Yu Q. Cell Death Differ; 2010 May 29; 17(5):801-10. PubMed ID: 19893569 [Abstract] [Full Text] [Related]
10. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines. Kitagawa M, Aonuma M, Lee SH, Fukutake S, McCormick F. Oncogene; 2008 Sep 11; 27(40):5303-14. PubMed ID: 18521084 [Abstract] [Full Text] [Related]
11. Differential requirement for dimerization partner DP between E2F-dependent activation of tumor suppressor and growth-related genes. Komori H, Goto Y, Kurayoshi K, Ozono E, Iwanaga R, Bradford AP, Araki K, Ohtani K. Sci Rep; 2018 May 31; 8(1):8438. PubMed ID: 29855511 [Abstract] [Full Text] [Related]
12. Apaf-1 is a transcriptional target for E2F and p53. Moroni MC, Hickman ES, Lazzerini Denchi E, Caprara G, Colli E, Cecconi F, Müller H, Helin K. Nat Cell Biol; 2001 Jun 31; 3(6):552-8. PubMed ID: 11389439 [Abstract] [Full Text] [Related]
13. Up-regulation of Bcl-2 homology 3 (BH3)-only proteins by E2F1 mediates apoptosis. Hershko T, Ginsberg D. J Biol Chem; 2004 Mar 05; 279(10):8627-34. PubMed ID: 14684737 [Abstract] [Full Text] [Related]
14. Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Hershko T, Chaussepied M, Oren M, Ginsberg D. Cell Death Differ; 2005 Apr 05; 12(4):377-83. PubMed ID: 15706352 [Abstract] [Full Text] [Related]
15. Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Zhao Y, Tan J, Zhuang L, Jiang X, Liu ET, Yu Q. Proc Natl Acad Sci U S A; 2005 Nov 01; 102(44):16090-5. PubMed ID: 16243973 [Abstract] [Full Text] [Related]
16. JNK activation is regulated by E2F and promotes E2F1-induced apoptosis. Bashari D, Hacohen D, Ginsberg D. Cell Signal; 2011 Jan 01; 23(1):65-70. PubMed ID: 20800677 [Abstract] [Full Text] [Related]
17. Ei24, a novel E2F target gene, affects p53-independent cell death upon ultraviolet C irradiation. Sung YH, Jin Y, Kang Y, Devkota S, Lee J, Roh JI, Lee HW. J Biol Chem; 2013 Oct 25; 288(43):31261-7. PubMed ID: 24014029 [Abstract] [Full Text] [Related]
18. RBM38 is a direct transcriptional target of E2F1 that limits E2F1-induced proliferation. Feldstein O, Ben-Hamo R, Bashari D, Efroni S, Ginsberg D. Mol Cancer Res; 2012 Sep 25; 10(9):1169-77. PubMed ID: 22798430 [Abstract] [Full Text] [Related]
19. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors. Shen Q, Uray IP, Li Y, Krisko TI, Strecker TE, Kim HT, Brown PH. Oncogene; 2008 Jan 10; 27(3):366-77. PubMed ID: 17637753 [Abstract] [Full Text] [Related]
20. Bim is a direct target of a neuronal E2F-dependent apoptotic pathway. Biswas SC, Liu DX, Greene LA. J Neurosci; 2005 Sep 14; 25(37):8349-58. PubMed ID: 16162916 [Abstract] [Full Text] [Related] Page: [Next] [New Search]